Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_assertion type Assertion NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_head.
- NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_assertion description "[Further work is needed to identify optimal platforms for CAR-based adoptive immunotherapy for leukemia, to establish guidelines for managing toxicity, and to determine whether the remissions induced by this approach can be rendered durable.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_provenance.
- NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_assertion evidence source_evidence_literature NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_provenance.
- NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_assertion SIO_000772 24319203 NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_provenance.
- NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_assertion wasDerivedFrom befree-20150227 NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_provenance.
- NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_assertion wasGeneratedBy ECO_0000203 NP642207.RAVI7SzbZGTVN8fMJEpPv1Gje8pV3Q5cNeqcG_fWhWH2U130_provenance.